Treat-to-Target urate-lowering therapy in primary gout patients: A real-world retrospective study at a dedicated gout clinic in China.

CONCLUSIONS: The long-term standard treat-to-target ULT strategy benefits patients for both gout-related issues and their extra-articular organs. The current study suggests that there is a better chance to achieve the rates of adherence to ULT and the target of sUA levels in the setting of a dedicated gout clinic.
PMID: 32444582 [PubMed - as supplied by publisher]

Source: Technology and Health Care - April 29, 2020 Category: Medical Devices Authors: Bai XS, Wang M, Cui LL, He YW, Wang C, Li XD, Qu XJ, Sun MS, Li CG Tags: Technol Health Care Source Type: research